Group 5
Looking for funding?
Looking for funding?

We can provide the know-how, connections and capital you need to grow your business

Talk to us
Gousto

Buoyed by its strong growth, Gousto achieved “unicorn” status in 2020, when it completed a funding round at a $1bn+ valuation

View case study
Sign up for updates

Stay up-to-date with all things BGF

Find out more
Miss Group

With BGF as a minority partner, web hosting company Miss Group acquired seven businesses in under two years, quadrupling its earnings

View case study

Supporting female founder initiatives across the UK & Ireland

Find out more  
← Back to portfolio Porfolio / DefiniGEN

DefiniGEN

A University of Cambridge supported company whose mission is to provide optimized human cell products to the scientific community.

Company overview

DefiniGEN is a spin-out from the University of Cambridge, creating highly predictive disease cell models for preclinical research and drug development. The process of bringing new drugs to market is arduous, expensive and blighted by a high failure rate. DefiniGEN’s models help the biopharma industry to respond to these challenges, enabling highly relevant information on potential new drug efficacy to be realised in an accelerated manner.

Website
DefiniGEN

Our technology platform harnesses iPSC technology to develop models that are transformational for drug discovery. We have gained significant commercial momentum in recent years, and this investment will be a significant driver of continued growth for DefiniGEN. We’re thrilled to be working with BGF, who understand the complex issues that we are addressing and are committed to helping us accelerate the next phase of growth.

Dr Marcus Yeo , CEO

Company information

Head office
  • Cambridge
CEO
  • Dr. Marcus Yeo
Chair
BGF office
BGF team
Investment date
  • Nov 2020
Total BGF investment
  • £2m

Business funding insights

STATS Group's subsea BICEP technology in Abu Dhabi
November 2023 / BGF Insights

A post-exit perspective—with Leigh Howarth, CEO of STATS Group

In August, we announced the successful exit of our investment in STATS Group, an Aberdeen-based pipeline technology specialist for the global energy…
Business funding International expansion Oil & gas Portfolio Technology
An aeroplane flies above the clouds. Aviation is a key aspect of international expansion
July 2023 / BGF Insights

How BGF is helping companies to expand internationally: Elvie & OSL

BGF can support your business to expand overseas, just as we did with fast-growing femtech company Elvie and counter-drone tech business OSL. Read the case studies to learn more.
Automotive & aerospace Business funding Retail, leisure & hospitality Technology
Andy Gregory, CEO of BGF
June 2023 / BGF Insights

Why mission matters – supporting entrepreneurs throughout the journey

Andy Gregory, CEO, and Ben Barker, head of portfolio, discuss why mission matters at BGF – and how to get exits right
Business funding CEO Blog Minority investment